RECEIVABLES

12 Months Ended

Dec. 31, 2011

Receivables [Abstract]

Receivables [Text Block]

Note 11. RECEIVABLES

Receivables include:

	December 31,
Dollars in Millions	2011		2010
Trade receivables	$	2,397	$	2,092
Less allowances		(147)		(107)
Net trade receivables		2,250		1,985
Alliance partners receivables		1,081		1,076
Prepaid and refundable income taxes		256		223
Miscellaneous receivables		156		196
Receivables	$	3,743	$	3,480

Receivables are netted with deferred income related to alliance partners until recognition of income. As a result, alliance partner receivables and deferred income were reduced by $901 million and $734million at December 31, 2011 and 2010, respectively. For additional information regarding alliance partners, see “—Note 3. Alliances and Collaborations.” Non-U.S. receivables sold on a nonrecourse basis were $1,077 million in 2011, $932 million in2010, and $660 million in 2009. In the aggregate, receivables due from three pharmaceutical wholesalers in the U.S. represented 55% and 51% of total trade receivables at December 31, 2011 and 2010, respectively.

Changes to the allowancesfor bad debt, charge-backs and cash discounts were as follows:

	Year Ended December 31,
Dollars in Millions	2011		2010		2009
Balance at beginning of year	$	107	$	103	$	128
Provision		1,094		864		776
Utilization		(1,054)		(860)		(800)
Discontinued operations		-		-		(1)
Balance at end of year	$	147	$	107	$	103